213 related articles for article (PubMed ID: 17477804)
1. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
Alayash AI; D'Agnillo F; Buehler PW
Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
[TBL] [Abstract][Full Text] [Related]
2. How to evaluate blood substitutes for endothelial cell toxicity.
Gaucher C; Menu P
Antioxid Redox Signal; 2008 Jul; 10(7):1153-62. PubMed ID: 18331203
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
[TBL] [Abstract][Full Text] [Related]
4. Oxygen therapeutics: can we tame haemoglobin?
Alayash AI
Nat Rev Drug Discov; 2004 Feb; 3(2):152-9. PubMed ID: 15043006
[TBL] [Abstract][Full Text] [Related]
5. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
6. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin.
D'Agnillo F; Alayash AI
Adv Drug Deliv Rev; 2000 Feb; 40(3):199-212. PubMed ID: 10837790
[TBL] [Abstract][Full Text] [Related]
7. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation.
Nagababu E; Ramasamy S; Rifkind JM; Jia Y; Alayash AI
Biochemistry; 2002 Jun; 41(23):7407-15. PubMed ID: 12044174
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
Buehler PW; D'Agnillo F; Schaer DJ
Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
[TBL] [Abstract][Full Text] [Related]
9. Acellular invertebrate hemoglobins as model therapeutic oxygen carriers: unique redox potentials.
Harrington JP; Kobayashi S; Dorman SC; Zito SL; Hirsch RE
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):53-67. PubMed ID: 17364471
[TBL] [Abstract][Full Text] [Related]
10. Molecular controls of the oxygenation and redox reactions of hemoglobin.
Bonaventura C; Henkens R; Alayash AI; Banerjee S; Crumbliss AL
Antioxid Redox Signal; 2013 Jun; 18(17):2298-313. PubMed ID: 23198874
[TBL] [Abstract][Full Text] [Related]
11. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
Jansman MMT; Hosta-Rigau L
Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
[TBL] [Abstract][Full Text] [Related]
12. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes.
Patel RP
Free Radic Biol Med; 2000 May; 28(10):1518-25. PubMed ID: 10927176
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.
Alayash AI
Shock; 2019 Oct; 52(1S Suppl 1):41-49. PubMed ID: 29112106
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin and free radicals: implications for the development of a safe blood substitute.
Alayash AI; Cashon RE
Mol Med Today; 1995 Jun; 1(3):122-7. PubMed ID: 9415147
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.
Simons M; Gretton S; Silkstone GGA; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Leiva-Eriksson N; Ronda L; Mozzarelli A; Strader MB; Alayash AI; Reeder BJ; Cooper CE
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802155
[TBL] [Abstract][Full Text] [Related]
16. Interaction of recombinant octameric hemoglobin with endothelial cells.
Gaucher C; Domingues-Hamdi É; Prin-Mathieu C; Menu P; Baudin-Creuza V
C R Biol; 2015 Feb; 338(2):95-102. PubMed ID: 25543885
[TBL] [Abstract][Full Text] [Related]
17. Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.
Cooper CE; Silkstone GGA; Simons M; Rajagopal B; Syrett N; Shaik T; Gretton S; Welbourn E; Bülow L; Eriksson NL; Ronda L; Mozzarelli A; Eke A; Mathe D; Reeder BJ
Free Radic Biol Med; 2019 Apr; 134():106-118. PubMed ID: 30594736
[TBL] [Abstract][Full Text] [Related]
18. Ferrous hemoglobin and hemoglobin-based oxygen carriers acting as a peroxidase can inhibit oxidative damage to endothelial cells caused by hydrogen peroxide.
Huo S; Lei X; He D; Zhang H; Yang Z; Mu W; Fang K; Xue D; Li H; Li X; Jia N; Zhu H; Chen C; Yan K
Artif Organs; 2021 Oct; 45(10):1229-1239. PubMed ID: 34101875
[TBL] [Abstract][Full Text] [Related]
19. Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.
Benitez Cardenas AS; Samuel PP; Olson JS
Shock; 2019 Oct; 52(1S Suppl 1):28-40. PubMed ID: 29112633
[TBL] [Abstract][Full Text] [Related]
20. Design of recombinant hemoglobins for use in transfusion fluids.
Fronticelli C; Koehler RC
Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]